Sentinel lymph node biopsy in breast cancer

Surgeon

Volumn 2, Issue 5, 2004, Pages 273-276

  Dowling, C M ^a   Hill, A D K ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Breast cancer staging; Sentinel lymph node biopsy

Indexed keywords

ISOSULFAN BLUE; RADIOISOTOPE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG HYPERSENSITIVITY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MOLECULAR PROBE; MORBIDITY; OUTCOMES RESEARCH; PATIENT SELECTION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 6444220464     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(04)80096-9     Document Type: Article

References (15)

1. Hill AD, Mann GB, Borgen PI, Cody HS III. Sentinel lymphatic mapping in breast cancer. J Am Coll Surg 1999; 188: 545-49.
2. Duff M, Hill AD, McGreal G, Walsh S, McDermott EW, O'Higgins NJ. Prospective evaluation of the morbidity of axillary clearance for breast cancer. Br J Surg 2001; 88: 114-17.
3. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel node biopsy in breast cancer patients. Br J Cancer 2003; 89: 648-52.
4. Rosen PP, Groshen S, Saigo, P, Kinne DW, Hellman S. A long-term follow-up study of survival in Stage I (T1N0M0) and stage II T1N1M0) breast carcinoma. J Clin Oncol 1989; 7: 355-66.
5. Kissen MW, Thompson EM, Price AB, Slavin G, Kark AE. The inadequacy of axillary sampling in breast cancer. Lancet 1982; 1 1210-12.
6. Benson EA, Thorogood J. The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 1986; 12: 267-71.
7. Forrest AP, Everington D, McDonald CC, Steele RJ, Chetty U, Stewarrt HJ. The Edinburgh randomised trial of axillary sampling or clearance after mastectomy. Br J Surg 1995; 82: 1504-8.
8. Hoe AL, Iven D, Royle GT, Taylor I. Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 1992; 79: 261-62.
9. O'Hea BJ, Hill ADK El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG et al. Sentinel lymph node biopsy in breast cancer: the initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-27.
10. Lin PP, Allison DC, Wainstock J, Miller KD, Dooley WC, Friedman N et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993; 11: 1536-44.
11. Petrek JA, Blackwood MM. Axillary dissection: current practice and technique. Curr Probl Surg 1995; 32: 257-23.
12. Hill AD, Tran KN, Akhurst T, Yeung H, Yeh SD, Rosen PP et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229: 528-35.
13. Fleming FJ, Hill AD, Kavanagh D, Quinn C, O'Doherty A, Collins CD et al. Intradermal radioisotope injection optimises sentinel lymph node identification in breast cancer. Eur J Surg Oncol 2003; 29: 835-38.
14. Nugent N, Hill AD, Casey M, Kelly L, Dijkstra B, Collins CD et al. Safety Guidelines for radiolocalised sentinel node resection. Ir J Med Sci 2001;170(4):236-38.
15. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Path 2004;57:695-701.